AdaptHealth Corp. (AHCO) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
AdaptHealth (AHCO) Q1 2026: Capitated Revenue Surges to 9.2% of Mix, Driving Margin Reset
May 05, 2026
-
AdaptHealth (AHCO) Q4 2025: Capitated Contract Adds 5%–6% Revenue Growth, Reshaping Home Medical Model
February 25, 2026
-
AdaptHealth (AHCO) Q3 2025: Organic Growth Hits 5.1% as Capitated Contracts Reshape Home Care Model
November 04, 2025
-
AdaptHealth (AHCO) Q2 2025: $1B Capitated Deal to Lift Recurring Revenue to 10%
August 05, 2025
-
AdaptHealth (AHCO) Q1 2025: Respiratory Outpaces as $25M Debt Cut Sharpens Focus on Core Growth
July 06, 2025
-
AdaptHealth (AHCO) Q3 2024: Diabetes Revenue Down $45M as Operational Reset Delays Segment Recovery
November 05, 2024
-
AdaptHealth (AHCO) Q2 2024: Sleep Revenue Climbs 6.5% as Portfolio Simplification and Tech Investments Accelerate
August 06, 2024
-
AdaptHealth (AHCO) Q1 2024: EBITDA Margin Expands 200bps as Supply Chain and Diabetes Execution Drive Upside
May 07, 2024
-
AdaptHealth (AHCO) Q4 2023: Sleep Resupply Census Hits 1.55 Million, Driving Margin Expansion
February 27, 2024